Melanotan II: Potent Biology, Tiny Human Evidence Base

Reviewed for accuracy by the Gorilla Research Insights research team · 2026-07-04

Melanotan II activates melanocortin biology strongly enough to produce visible and physiological effects. The human evidence base, however, is small and old.

What Human Studies Actually Showed

A pilot phase 1 experiment included only three healthy male volunteers. It reported increased pigmentation alongside nausea, fatigue or somnolence, yawning, stretching, and spontaneous erections ^[1]. A separate double-blind crossover study in ten men with psychogenic erectile dysfunction reported erectile responses and more nausea, stretching, yawning, and appetite reduction than placebo ^[2].

Why That Is Not a Safety Verdict

Three- and ten-person studies cannot establish uncommon harms, long-term dermatologic risk, broad efficacy, or a favorable benefit-risk profile. They also do not establish that a separate research product matches the material studied. Melanotan II is not afamelanotide and should not inherit afamelanotide’s approval.

The missing evidence is the headline

Early human experiments can establish that a compound produces observable biological effects; they do not automatically establish an acceptable benefit-risk profile. Here, the samples were tiny, follow-up was limited, and the recorded adverse effects were not subtle background noise ^[1][2]. Rare events, pigment changes over time, interactions, and outcomes across diverse populations remain outside what those studies can answer. A credible modern program would require well-characterized material, registered protocols, dermatologic monitoring, systematic adverse-event collection, longer observation, and enough participants to narrow uncertainty. Until then, Melanotan II occupies an evidence category that hype hates but science needs: biologically active, investigated in humans, and nowhere near comprehensively characterized ^[1][2].

Primary Sources

• ^[1] Melanotan II pilot phase 1 study . • ^[2] Double-blind placebo-controlled crossover study . Educational research summary only; not medical advice. Research materials are not for human use.